Amendment 1, after citation 2
Future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness
A10-0123/2025 – Hildegard Bentele – After citation 2 – Am 1
Rejected
- For
- 226
- Against
- 409
- Abstained
- 17
roll-call vote at 13:15 · 35% of votes cast in favour
Roll call requested by Members
How the groups voted
A group’s line is the position at least two thirds of its voting MEPs took; otherwise it is shown as Divided. Groups from left to right.
| Group | For | Against | Abstained | of | Line |
|---|---|---|---|---|---|
| The Left | 0 | 36 | 2 | 38 | Against |
| Greens | 0 | 52 | 0 | 52 | Against |
| S&D | 2 | 116 | 0 | 118 | Against |
| Renew | 0 | 68 | 0 | 68 | Against |
| EPP | 36 | 132 | 7 | 175 | Against |
| ECR | 65 | 1 | 6 | 72 | For |
| Patriots | 79 | 0 | 0 | 79 | For |
| ESN | 25 | 0 | 0 | 25 | For |
| No group | 19 | 4 | 2 | 25 | — |
“of” = MEPs of the group who voted. Groups as they are now.
Every MEP
652 MEPs voted. Open a group, or filter above.
The Left 38 MEPs
Greens 52 MEPs
S&D 118 MEPs
Renew 68 MEPs
EPP 175 MEPs
ECR 72 MEPs
Patriots 79 MEPs
ESN 25 MEPs
No group 25 MEPs
“Votes in which an MEP voted differently from their group: on decision pages, against a line at least two thirds of the group took; in loyalty figures, against the position most of the group took.” = voted otherwise than a clear line (two thirds of its votes) of the group they sit in now. MEPs with no vote recorded are not listed.